Wayland Group WKN: A2PAPZ ISIN: CA9442041062 Kürzel: MRRCF Forum: Aktien Thema: Hauptdiskussion

0,0000 USD
±0,00 % ±0,0000
24. September 2026, 02:10 Uhr, Nasdaq OTC
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.
Kommentare 14.610
MYMaerta
MYMaerta, 21.04.2018 20:10 Uhr
0
Mal schauen was am Montag mittag in Kanada passiert.
MYMaerta
MYMaerta, 21.04.2018 20:04 Uhr
0
MARICANN hat gestern sein 3tes Lizenz bekommen.
L
LikeCGC, 20.04.2018 15:15 Uhr
0
https://gmpsecurities.com/Portals/0/ConferencesEvents/PDF/GMP_Cannabis_Conference_2018.pdf Schaut mal hier rein. Hier steht Maricann unter TSX gelistet. hab ja nicht mehr damit gerechnet, aber vielleicht wird es ja doch wahr.
MYMaerta
MYMaerta, 19.04.2018 11:56 Uhr
0
Maricann Subsidiary, Mariplant, Commences Hemp Operations in Germany TORONTO, April 18, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF) (“Maricann” or the “Company”), is pleased to announce that the first seeds will be planted today on its contract farmed 164 hectares (~405 acre) of agricultural land in Saxony, Germany, through Mariplant GmbH a 95% owned subsidiary of the Company focused on nutraceutical non-THC cannabis. The cultivation site is less than 30 minutes drive from the Company’s Ebersbach Campus, near Dresden, Germany. The Ebersbach facility is currently under retrofit of 8,000 sq. m (86,111 sq. ft) separated from its Maricann GmbH operations, to accommodate drying equipment capable of processing 1,000 kg of wet cannabis per hour. Storage and extraction equipment from Advanced Extraction Systems (AES) will be utilized to process up to 200 kg of cannabis flowers per day.1 Mariplant’s operation will focus on producing isolates of CBD and CBG, which are considered to be the most desirable cannabinoids. Maricann will add terpenoids and flavonoids in addition to its VesiSorb emulsion technology to create Mariplant products for distribution as food supplements across Germany and the greater European Union. Terpenoids and Flavonoids from Maricann’s Haxxon cultivation and extraction operation from feminized cannabis will be added to improve efficacy. We believe that this large scale outdoor cannabis cultivation and extraction operation has the potential to reduce our costs of production significantly, specifically for isolate CBD, CBN and CBG. Through this initiative, we expect to be able to produce our own active ingredients for our products, reducing material costs of active ingredients for Mariplant products that we currently purchase from third parties. Ben Ward, CEO of Maricann Our expectation is that this will result in a further competitive advantage for Mariplant, benefiting in a differentiated product through VesiSorb’s patented delivery technology, with the end result of value creation for Maricann shareholders. Mariplant is a standalone company in Germany registered for agriculture, with its General Manager Josef Spaeth who has the designation of registered farmer (Landwirt). Mariplant will sell finished product VesiSorb gel capsules into the German market through its online shop www.mariplant.
R
Ronin275, 18.04.2018 23:07 Uhr
0
http://business.financialpost.com/sponsored/business-sponsored/canadas-world-class-template-has-set-the-stage-for-european-countries
b
brokerbroker1, 18.04.2018 22:49 Uhr
0
Das Ausschreibungsverfahren muss wiederholt werden. Wie können da Samen eingesetzt werden. 2019 war der alte Zeitplan.
Z
ZoArTeN, 18.04.2018 21:18 Uhr
0
Das läuft noch kam sogar im Fernsehen aber weil die Gerichtsverfahren so lange Dauern wir es wohl 2019 bis sich was tut
b
brokerbroker1, 18.04.2018 18:54 Uhr
0
Wie geht das, wenn das Gericht doch das ausschreibungsverfahren gekippt hat? Oder hab ich was falsch verstanden
MYMaerta
MYMaerta, 18.04.2018 16:27 Uhr
0
Danke euch
H
Hyper_Hyper, 18.04.2018 16:12 Uhr
0
MARICANN GROUP INC ("MRRCF-0") - Maricann Subsidiary, Mariplant, Commences Hemp Operations - in Germany Maricann Group Inc. ("Maricann" or the "Company"), is pleased to announce that the first seeds will be planted today on its contract farmed 164 hectares (~405 acre) of agricultural land in Saxony, Germany, through Mariplant GmbH a 95% owned subsidiary of the Company focused on nutraceutical non-THC cannabis. The cultivation site is less than 30 minutes drive from the Company's Ebersbach Campus, near Dresden, Germany. The Ebersbach facility is currently under retrofit of 8,000 sq. m (86,111 sq. ft) separated from its Maricann GmbH operations, to accommodate drying equipment capable of processing 1,000 kg of wet cannabis per hour. Storage and extraction equipment from Advanced Extraction Systems (AES) will be utilized to process up to 200 kg of cannabis flowers per day.1 Mariplant's operation will focus on producing isolates of CBD and CBG, which are considered to be the most desirable cannabinoids. Maricann will add terpenoids and flavonoids in addition to its VesiSorb emulsion technology to create Mariplant products for distribution as food supplements across Germany and the greater European Union. Terpenoids and Flavonoids from Maricann's Haxxon cultivation and extraction operation from feminized cannabis will be added to improve efficacy. Ben Ward, CEO of Maricann stated, "We believe that this large scale outdoor cannabis cultivation and extraction operation has the potential to reduce our costs of production significantly, specifically for isolate CBD, CBN and CBG. Through this initiative, we expect to be able to produce our own active ingredients for our products, reducing material costs of active ingredients for Mariplant products that we currently purchase from third parties. Our expectation is that this will result in a further competitive advantage for Mariplant, benefiting in a differentiated product through VesiSorb's patented delivery technology, with the end result of value creation for Maricann shareholders". Mariplant is a standalone company in Germany registered for agriculture, with its General Manager Josef Spaeth who has the designation of registered farmer (Landwirt). Mariplant will sell finished product VesiSorb gel capsules into the German market through its online shop
H
Hyper_Hyper, 18.04.2018 15:55 Uhr
0
Ist ein Auszug der Marican Facebook Gruppe
H
Hyper_Hyper, 18.04.2018 15:51 Uhr
0
I keep an updated list to remind myself why I own a shit load of Maricann, helps to keep it all in perspective. This is what you can buy for under 2 bucks a share, crazy cheap!!! MARICANN INC. • 4th largest production at legalization • 95000kgs per year by 2019 below $1/gram • Vesisorb • Purchasing Haxxon in Switzerland closing May 2018 - CBD Cigarettes and gateway into European markets • Referral program agreement with 2100 Drug stores in Canada starting in May 2018 • Mckessen connection • One of a few LP's with capsule license • Export Permit from Health Canada • GMP Certification for Canadian location pending, should be very soon. • Germany - 75K Sq Ft retrofitted clean room ready now - with a total of 820K sq ft of clean room expansion available. Already GMP and GPP Compliant. Streaming financing in place for expansion. • A total of 600 hectares of farm land for Hemp (CBD) production in Germany and in Switzerland (?) • LOI with ABLE • Alliance of Beverage Licensees • Top bands like Rare Dankness and juju • Extremely low market cap for a company of this size If I am missing anything please let me know.
R
Ronin275, 18.04.2018 15:33 Uhr
0
https://globenewswire.com/news-release/2018/04/18/1480963/0/en/Maricann-Subsidiary-Mariplant-Commences-Hemp-Operations-in-Germany.html
L
LikeCGC, 18.04.2018 15:03 Uhr
0
GMP („Good Manufacturing Practice“) Dient zur Qualitätssicherung von Arzneimitteln. Viele Bereiche verwenden nur GMP zertifizierte Arzneimittel, da diese unter hohen Qualitätsmerkmalen hergestellt werden.
MYMaerta
MYMaerta, 17.04.2018 13:55 Uhr
0
Habs kopiert von WJ . Ich kann es bestätigen dass es so ist , bin nämlich öfters in der Schweiz unterwegs
MYMaerta
MYMaerta, 17.04.2018 13:54 Uhr
0
Der Markt für legales Cannabis floriert in der Schweiz. Laut Angaben des Blicks schätzt die Zollverwaltung, dass durch den Cannabis-Markt in diesem Jahr zusätzliche 15 Millionen Franken Steuern eingehen werden. Definitive Zahlen würden jedoch erst im nächsten Jahr präsentiert. Gemäss dem «Blick» sind Unternehmen im TOP-Land die Platzhirsche im legalen Schweizer Cannabis-Markt: Der grösste Produzent, Biocan, hat seinen Sitz in Thayngen SH und erwartet bis Ende Jahr eine Hanf-Ernte von gesamthaft zwölf bis 15 Tonnen. Auch die Firmen Medropharm mit Sitz in Kradolf-Schönenberg TG sowie die Appenzeller Produzenten Ai Fame gehören zu den grösseren Herstellern von legalem Cannabis. Das legale Cannabis hat einen THC-Wert von unter einem Prozent und ist seit dem letzten Sommer legal. Es wird unter anderem zu Hanf-Zigaretten verarbeitet, die bei Coop, k kiosk und anderen Detailhändlern erhältlich sind. Die Nachfrage nach den Produkten ist riesig: An  vielen Verkaufsstellen waren die CBD-Zigaretten nach dem Verkaufsstart diesen Sommer wiederholt ausverkauft.
Meistdiskutiert
Thema
1 Brainchip Klassengruppe +6,65 %
2 GEVO Hauptdiskussion -1,29 %
3 GECINA Hauptdiskussion +1,17 %
4 APLD - 2024 -2,21 %
5 ITM POWER Hauptdiskussion -4,07 %
6 MDATA +4,12 %
7 NIO INC.A S.ADR DL-,00025 Hauptdiskussion +1,63 %
8 Security der nächsten Generation -0,92 %
9 BLOOM ENERGY A Hauptdiskussion -0,74 %
10 Plug Power ohne Spam -0,05 %
Alle Diskussionen
Aktien
Thema
1 Brainchip Klassengruppe +6,65 %
2 GEVO Hauptdiskussion -1,29 %
3 GECINA Hauptdiskussion +1,17 %
4 APLD - 2024 -2,21 %
5 ITM POWER Hauptdiskussion -4,07 %
6 MDATA +4,12 %
7 NIO INC.A S.ADR DL-,00025 Hauptdiskussion +1,63 %
8 Security der nächsten Generation -0,92 %
9 BLOOM ENERGY A Hauptdiskussion -0,74 %
10 Plug Power ohne Spam -0,05 %
Alle Diskussionen